CN1635855A - 靶向血管系统的磁共振成像系统和方法 - Google Patents
靶向血管系统的磁共振成像系统和方法 Download PDFInfo
- Publication number
- CN1635855A CN1635855A CNA028192532A CN02819253A CN1635855A CN 1635855 A CN1635855 A CN 1635855A CN A028192532 A CNA028192532 A CN A028192532A CN 02819253 A CN02819253 A CN 02819253A CN 1635855 A CN1635855 A CN 1635855A
- Authority
- CN
- China
- Prior art keywords
- mri
- contrast agent
- data set
- fixed target
- targeting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002792 vascular Effects 0.000 title claims abstract description 174
- 238000000034 method Methods 0.000 title claims abstract description 145
- 238000002595 magnetic resonance imaging Methods 0.000 title description 132
- 239000002616 MRI contrast agent Substances 0.000 claims abstract description 135
- 241000124008 Mammalia Species 0.000 claims abstract description 42
- 230000003143 atherosclerotic effect Effects 0.000 claims abstract description 14
- 230000003902 lesion Effects 0.000 claims abstract description 14
- 230000008685 targeting Effects 0.000 claims description 195
- 239000002872 contrast media Substances 0.000 claims description 168
- 210000004204 blood vessel Anatomy 0.000 claims description 123
- 210000004369 blood Anatomy 0.000 claims description 108
- 239000008280 blood Substances 0.000 claims description 108
- 208000007536 Thrombosis Diseases 0.000 claims description 75
- 229940039231 contrast media Drugs 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 31
- 229920001222 biopolymer Polymers 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 16
- 239000004531 microgranule Substances 0.000 claims description 16
- 238000003780 insertion Methods 0.000 claims description 14
- 230000037431 insertion Effects 0.000 claims description 14
- 238000010494 dissociation reaction Methods 0.000 claims description 13
- 230000005593 dissociations Effects 0.000 claims description 13
- 102000004895 Lipoproteins Human genes 0.000 claims description 12
- 108090001030 Lipoproteins Proteins 0.000 claims description 12
- 102000009123 Fibrin Human genes 0.000 claims description 10
- 108010073385 Fibrin Proteins 0.000 claims description 10
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 10
- 229950003499 fibrin Drugs 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 8
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 8
- 235000013980 iron oxide Nutrition 0.000 claims description 8
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 7
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 208000005189 Embolism Diseases 0.000 claims description 6
- 102000008946 Fibrinogen Human genes 0.000 claims description 6
- 108010049003 Fibrinogen Proteins 0.000 claims description 6
- 102000006395 Globulins Human genes 0.000 claims description 6
- 108010044091 Globulins Proteins 0.000 claims description 6
- 102000012404 Orosomucoid Human genes 0.000 claims description 6
- 108010061952 Orosomucoid Proteins 0.000 claims description 6
- 208000001435 Thromboembolism Diseases 0.000 claims description 6
- 206010045168 Tumour embolism Diseases 0.000 claims description 6
- 229940012952 fibrinogen Drugs 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 150000002632 lipids Chemical group 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- HBEAOBRDTOXWRZ-UHFFFAOYSA-K gadoversetamide Chemical compound [Gd+3].COCCNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NCCOC HBEAOBRDTOXWRZ-UHFFFAOYSA-K 0.000 claims description 3
- 229960002059 gadoversetamide Drugs 0.000 claims description 3
- DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 claims description 2
- 238000001802 infusion Methods 0.000 claims 2
- PCZHWPSNPWAQNF-LMOVPXPDSA-K 2-[[(2s)-2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+);hydron Chemical compound [Gd+3].CCOC1=CC=C(C[C@@H](CN(CCN(CC(O)=O)CC([O-])=O)CC([O-])=O)N(CC(O)=O)CC([O-])=O)C=C1 PCZHWPSNPWAQNF-LMOVPXPDSA-K 0.000 claims 1
- MXZROTBGJUUXID-UHFFFAOYSA-I [Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)C(C([O-])=O)COCC1=CC=CC=C1 Chemical compound [Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)C(C([O-])=O)COCC1=CC=CC=C1 MXZROTBGJUUXID-UHFFFAOYSA-I 0.000 claims 1
- HZHFFEYYPYZMNU-UHFFFAOYSA-K gadodiamide Chemical compound [Gd+3].CNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NC HZHFFEYYPYZMNU-UHFFFAOYSA-K 0.000 claims 1
- GFSTXYOTEVLASN-UHFFFAOYSA-K gadoteric acid Chemical compound [Gd+3].OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 GFSTXYOTEVLASN-UHFFFAOYSA-K 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 30
- 239000003153 chemical reaction reagent Substances 0.000 description 55
- 238000002347 injection Methods 0.000 description 38
- 239000007924 injection Substances 0.000 description 38
- 238000011161 development Methods 0.000 description 30
- 230000018109 developmental process Effects 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 23
- 210000004731 jugular vein Anatomy 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 16
- 210000003462 vein Anatomy 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 14
- 210000001715 carotid artery Anatomy 0.000 description 13
- 206010002091 Anaesthesia Diseases 0.000 description 12
- 230000037005 anaesthesia Effects 0.000 description 12
- 125000001151 peptidyl group Chemical group 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- 230000002708 enhancing effect Effects 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 8
- 210000004088 microvessel Anatomy 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 238000002601 radiography Methods 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000002583 angiography Methods 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 229960002275 pentobarbital sodium Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 4
- 241000294142 Vascellum Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 4
- 208000010125 myocardial infarction Diseases 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- 206010002329 Aneurysm Diseases 0.000 description 3
- 101000651439 Homo sapiens Prothrombin Proteins 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- LGMLJQFQKXPRGA-VPVMAENOSA-K gadopentetate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O LGMLJQFQKXPRGA-VPVMAENOSA-K 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940039715 human prothrombin Drugs 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 229910052688 Gadolinium Inorganic materials 0.000 description 2
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015624 blood vessel development Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001300078 Vitrea Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000012822 chemical development Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010968 computed tomography angiography Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- SLYTULCOCGSBBJ-UHFFFAOYSA-I disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+) Chemical compound [Na+].[Na+].[Gd+3].CCOC1=CC=C(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)C=C1 SLYTULCOCGSBBJ-UHFFFAOYSA-I 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- OCDAWJYGVOLXGZ-VPVMAENOSA-K gadobenate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)C(C([O-])=O)COCC1=CC=CC=C1 OCDAWJYGVOLXGZ-VPVMAENOSA-K 0.000 description 1
- RJOJUSXNYCILHH-UHFFFAOYSA-N gadolinium(3+) Chemical compound [Gd+3] RJOJUSXNYCILHH-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- High Energy & Nuclear Physics (AREA)
- Radiology & Medical Imaging (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30869001P | 2001-07-30 | 2001-07-30 | |
| US60/308,690 | 2001-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1635855A true CN1635855A (zh) | 2005-07-06 |
Family
ID=23194994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA028192532A Pending CN1635855A (zh) | 2001-07-30 | 2002-07-30 | 靶向血管系统的磁共振成像系统和方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7412279B2 (fr) |
| EP (1) | EP1420689A4 (fr) |
| JP (3) | JP2004536649A (fr) |
| KR (1) | KR20040018529A (fr) |
| CN (1) | CN1635855A (fr) |
| AU (1) | AU2002322789C1 (fr) |
| BR (1) | BR0211607A (fr) |
| CA (1) | CA2455210A1 (fr) |
| HU (1) | HUP0401548A3 (fr) |
| IL (1) | IL159937A0 (fr) |
| MX (1) | MXPA04000955A (fr) |
| PL (1) | PL366736A1 (fr) |
| TW (1) | TWI221406B (fr) |
| WO (1) | WO2003011113A2 (fr) |
| ZA (1) | ZA200401605B (fr) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100581456C (zh) * | 2006-11-22 | 2010-01-20 | 株式会社东芝 | 磁共振成像装置 |
| CN102188722A (zh) * | 2010-03-18 | 2011-09-21 | 中国科学院福建物质结构研究所 | 一种含二价铁的磁共振成像造影剂 |
| CN103519809A (zh) * | 2013-10-22 | 2014-01-22 | 深圳先进技术研究院 | 氧代谢参数估测方法和系统 |
| CN106986920A (zh) * | 2017-03-09 | 2017-07-28 | 北京市心肺血管疾病研究所 | 四型胶原作为靶点在早期诊断主动脉瘤/夹层中的应用 |
| CN108430520A (zh) * | 2015-11-06 | 2018-08-21 | 威斯康星校友研究基金会 | 长效钆基肿瘤靶向成像与治疗剂 |
| US10098563B2 (en) | 2006-11-22 | 2018-10-16 | Toshiba Medical Systems Corporation | Magnetic resonance imaging apparatus |
| CN111738977A (zh) * | 2019-03-19 | 2020-10-02 | 西门子医疗有限公司 | 用于提供决策支持数据的方法和数据处理系统 |
| CN112426143A (zh) * | 2020-11-16 | 2021-03-02 | 清华大学 | 一种肾动脉及腹主动脉一站式无创磁共振血管壁成像系统 |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1542709A2 (fr) * | 2002-08-06 | 2005-06-22 | EPIX Pharmaceuticals, Inc. | Agregats de peptides |
| CN100501439C (zh) * | 2002-08-27 | 2009-06-17 | 肯尼迪克里格学院 | 微脉管血容量磁共振成像 |
| EP1420367A1 (fr) * | 2002-11-15 | 2004-05-19 | MeVis GmbH | Méthode pour colorer des voxels et traitement de données d'image et système de visualisation |
| AR047692A1 (es) * | 2003-07-10 | 2006-02-08 | Epix Medical Inc | Imagenes de blancos estacionarios |
| US20060052690A1 (en) * | 2004-09-08 | 2006-03-09 | Sirohey Saad A | Contrast agent imaging-driven health care system and method |
| MX2007009354A (es) * | 2005-02-03 | 2008-01-14 | Epix Pharm Inc | Metodos de perfusion en estado estable. |
| WO2006122203A1 (fr) * | 2005-05-11 | 2006-11-16 | The University Of Houston System | Systeme de magnetocapteur intraluminal et procede d'utilisation |
| US20090295385A1 (en) * | 2005-05-11 | 2009-12-03 | Audrius Brazdeikis | Magneto Sensor System and Method of Use |
| US8380279B2 (en) * | 2005-05-11 | 2013-02-19 | The University Of Houston System | Intraluminal multifunctional sensor system and method of use |
| US20100259259A1 (en) * | 2005-09-21 | 2010-10-14 | Markus Zahn | Systems and methods for tuning properties of nanoparticles |
| US20070237372A1 (en) * | 2005-12-29 | 2007-10-11 | Shoupu Chen | Cross-time and cross-modality inspection for medical image diagnosis |
| US20080058636A1 (en) | 2005-12-29 | 2008-03-06 | Epix Pharmaceuticals, Inc. | Methods of myocardial imaging |
| WO2007107931A2 (fr) * | 2006-03-17 | 2007-09-27 | Koninklijke Philips Electronics N.V. | Combinaison d'images par résonance magnétique |
| DE102006018413A1 (de) * | 2006-04-20 | 2007-10-25 | Siemens Ag | MR-Tomograph mit einem System zur Kontrastoptimierung von MRT-Bildern |
| DE102006037284B4 (de) * | 2006-08-09 | 2015-11-26 | Siemens Aktiengesellschaft | Verfahren und Vorrichtung zur Darstellung von Myokardgeweben unterschiedlicher Schädigungszustände |
| WO2009089088A1 (fr) * | 2008-01-04 | 2009-07-16 | The Ohio State University Research Foundation | Procédés de caractérisation des plaques athérosclérotiques in vivo utilisant la susceptibilité magnétique pour identifier les plaques produisant des symptômes |
| US8557290B2 (en) * | 2008-03-14 | 2013-10-15 | Northwestern University | Multifunction nanoconjugates for imaging applications and targeted treatment |
| EP2161064A1 (fr) | 2008-08-26 | 2010-03-10 | SICCE S.p.A. | Dispositif de filtration pour bassin et similaires |
| WO2010068486A1 (fr) * | 2008-11-25 | 2010-06-17 | Trustees Of Boston University | Appareil et procédé d'analyse de plaque artérielle |
| WO2010121133A2 (fr) | 2009-04-17 | 2010-10-21 | The General Hospital Corporation | Imagerie multimodale de fibrine |
| AU2010226479A1 (en) | 2009-03-19 | 2011-09-22 | Wyeth Llc | Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7) -en-2-yl)ethyl]phosphonic acid and precursors thereof |
| KR101049915B1 (ko) * | 2009-09-14 | 2011-07-15 | 울산대학교 산학협력단 | 혈관 내 초음파 영상을 이용한 혈관 내 죽상 경화반 성분 측정 장치 및 방법 |
| US9046593B2 (en) * | 2011-12-15 | 2015-06-02 | The Boeing Company | Method and apparatus for detecting and classifying signals |
| US9849201B2 (en) | 2013-05-03 | 2017-12-26 | Washington University | Homing agents |
| US10545209B2 (en) * | 2013-12-02 | 2020-01-28 | Northwestern University | System and method for acquiring both T2*-weighted and T1-weighted data in a single acquisition using a single dose of contrast agent |
| US9058692B1 (en) | 2014-04-16 | 2015-06-16 | Heartflow, Inc. | Systems and methods for image-based object modeling using multiple image acquisitions or reconstructions |
| US9514530B2 (en) | 2014-04-16 | 2016-12-06 | Heartflow, Inc. | Systems and methods for image-based object modeling using multiple image acquisitions or reconstructions |
| KR101535385B1 (ko) * | 2014-06-17 | 2015-07-08 | 연세대학교 산학협력단 | 자기 공명 영상 촬영 장치 및 방법 |
| DE102015203181A1 (de) * | 2015-02-23 | 2016-08-25 | Karl-Franzens-Universität Graz | Verfahren zur zeitlichen und räumlichen Interpolation von fMRI-Zeitreihen in Bezug auf ein Einzelsubjekt |
| JP2018523671A (ja) | 2015-08-13 | 2018-08-23 | ザ ジェネラル ホスピタル コーポレイション | 分子ｍｒイメージング用マンガン系キレートコンジュゲート |
| US11353533B2 (en) | 2016-02-24 | 2022-06-07 | Ohio State Innovation Foundation | Methods and devices for contrast agent magnetic resonance imaging |
| KR102581945B1 (ko) * | 2017-02-07 | 2023-09-25 | 삼성전자주식회사 | 스킨 정보 제공 방법 및 이를 지원하는 전자 장치 |
| US11789104B2 (en) | 2018-08-15 | 2023-10-17 | Hyperfine Operations, Inc. | Deep learning techniques for suppressing artefacts in magnetic resonance images |
| JP2022526718A (ja) * | 2019-03-14 | 2022-05-26 | ハイパーファイン，インコーポレイテッド | 空間周波数データから磁気共鳴画像を生成するための深層学習技術 |
| CN114663362B (zh) * | 2022-03-04 | 2024-03-29 | 强联智创（北京）科技有限公司 | 一种融合方法、装置以及设备 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880008A (en) * | 1985-05-08 | 1989-11-14 | The General Hospital Corporation | Vivo enhancement of NMR relaxivity |
| US4777957A (en) * | 1985-06-14 | 1988-10-18 | General Electric Company | Method for measuring and imaging fluid flow |
| AU6621586A (en) * | 1985-11-18 | 1987-06-02 | University Of Texas System, The | Polychelating agents for image and spectral enhancement (and spectral shift) |
| IL83567A (en) | 1986-08-18 | 1992-02-16 | Dow Chemical Co | Starburst conjugates with a carried material,such as an agricultural or pharmaceutical material |
| US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
| GB8808305D0 (en) * | 1988-04-08 | 1988-05-11 | Nycomed As | Compositions |
| US5914095A (en) * | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
| US5695739A (en) * | 1989-06-30 | 1997-12-09 | Schering Aktiengesellschaft | Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production |
| GB9320277D0 (en) | 1993-10-01 | 1993-11-17 | Nycomed Salutar Inc | Chelants |
| SG49726A1 (en) | 1989-10-23 | 1998-06-15 | Nycomed Salutar Inc | Compounds |
| US5650133A (en) * | 1990-01-19 | 1997-07-22 | Nycomed Salutar | Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality |
| DE3938992A1 (de) * | 1989-11-21 | 1991-05-23 | Schering Ag | Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| US5631329A (en) | 1990-08-27 | 1997-05-20 | Dendritech, Inc. | Process for producing hyper-comb-branched polymers |
| DE4115789A1 (de) * | 1991-05-10 | 1992-11-12 | Schering Ag | Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| CA2102605A1 (fr) * | 1991-05-23 | 1992-11-24 | Evan C. Unger | Substances liposolubles pour l'imagerie a resonance magnetique |
| US5522390A (en) * | 1991-11-21 | 1996-06-04 | U.S. Philips Corporation | Magnetic resonance imaging method |
| US5637759A (en) * | 1992-07-30 | 1997-06-10 | The Regents Of The University Of California | Metal-ligating amino acid derivatives for MRI and for peptide synthesis |
| ES2182833T3 (es) * | 1992-10-02 | 2003-03-16 | Diatide Inc | Agentes antitromboticos multimeros polivalentes. |
| US5726304A (en) | 1992-10-30 | 1998-03-10 | The University Of British Columbia | Porphocyanine and CNC-expanded porphyrins |
| US5401493A (en) * | 1993-03-26 | 1995-03-28 | Molecular Biosystems, Inc. | Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same |
| US5368033A (en) | 1993-04-20 | 1994-11-29 | North American Philips Corporation | Magnetic resonance angiography method and apparatus employing an integration projection |
| US5579767A (en) * | 1993-06-07 | 1996-12-03 | Prince; Martin R. | Method for imaging abdominal aorta and aortic aneurysms |
| US5417213A (en) * | 1993-06-07 | 1995-05-23 | Prince; Martin R. | Magnetic resonance arteriography with dynamic intravenous contrast agents |
| GB9314499D0 (en) | 1993-07-12 | 1993-08-25 | Nycomed Imaging As | Method |
| GB9318550D0 (en) | 1993-09-07 | 1993-10-20 | Nycomed Salutar Inc | Chelants |
| JPH09505819A (ja) * | 1993-12-03 | 1997-06-10 | ブラッコ エッセ．ピ．ア． | 核磁気共鳴診断用常磁性キレート |
| DE4344460A1 (de) | 1993-12-22 | 1995-06-29 | Schering Ag | Metallkomplexe von dendrimeren Makromolekülen, diese enthaltende diagnostische Mittel sowie Verfahren zur Herstellung der Komplexe und Mittel |
| WO1995025761A1 (fr) | 1994-03-22 | 1995-09-28 | Asahi Kasei Kogyo Kabushiki Kaisha | Procede de stabilisation des extremites moleculaires d'un copolymere d'oxymethylene |
| EP0702677A1 (fr) * | 1994-04-08 | 1996-03-27 | BRACCO International B.V. | Composes amides aromatiques et leurs chelates metalliques |
| US5582814A (en) | 1994-04-15 | 1996-12-10 | Metasyn, Inc. | 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging |
| GB9407812D0 (en) | 1994-04-20 | 1994-06-15 | Nycomed Salutar Inc | Compounds |
| IT1269839B (it) * | 1994-05-26 | 1997-04-15 | Bracco Spa | Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi |
| DE4425857A1 (de) | 1994-07-07 | 1996-01-11 | Schering Ag | Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| DK0783325T3 (da) | 1994-09-27 | 2000-05-01 | Nycomed Imaging As | Kontrastmiddel |
| US6232295B1 (en) | 1994-10-12 | 2001-05-15 | Jon Faiz Kayyem | Cell-specific contrast agent and gene delivery vehicles |
| TW319763B (fr) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
| DE19518222A1 (de) | 1995-05-11 | 1996-11-14 | Schering Ag | Verwendung von polymeren Kontrastmittel mittleren Molekulargewichts zur Differenzierung von benignen und malignen Tumoren mittels moderner bildgebender Verfahren |
| DE19521945A1 (de) | 1995-06-12 | 1996-12-19 | Schering Ag | Kaskadenpolymere mit Iodaromaten |
| DE19525924A1 (de) | 1995-07-04 | 1997-01-09 | Schering Ag | Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| US5888576A (en) * | 1995-07-11 | 1999-03-30 | Nissho Iwai Corporation | Edible shrimp product and method of making |
| US5919442A (en) | 1995-08-11 | 1999-07-06 | Dendritech, Inc. | Hyper comb-branched polymer conjugates |
| IT1277596B1 (it) | 1995-09-15 | 1997-11-11 | Bracco Spa | Composti macromolecolari di tipo dendrimerico |
| US6638508B2 (en) * | 1995-12-21 | 2003-10-28 | Yeda Research And Development Co., Ltd. | Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system |
| AU716667B2 (en) | 1996-01-10 | 2000-03-02 | Nycomed Imaging As | Contrast media |
| IT1283218B1 (it) | 1996-03-08 | 1998-04-16 | Bracco Spa | Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi |
| CN1108824C (zh) | 1996-04-01 | 2003-05-21 | Epix医学公司 | 生物活化的诊断成像造影剂 |
| US6054114A (en) | 1996-05-08 | 2000-04-25 | Massachusetts Institute Of Technology | Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro |
| IT1283651B1 (it) | 1996-08-02 | 1998-04-23 | Bracco Spa | Chelati paramagnetici ad alta relassivita' in siero |
| IT1283650B1 (it) | 1996-08-02 | 1998-04-23 | Bracco Spa | Chelati paramagnetici ad alta relassivita' in siero |
| DE19707708C2 (de) | 1997-02-26 | 2002-01-10 | Infineon Technologies Ag | Strombegrenzungsschaltung |
| WO1998041241A1 (fr) | 1997-03-18 | 1998-09-24 | Nihon Schering K. K. | Milieux de contraste pour irm, reconnaissant les modifications de l'environnement |
| US6061587A (en) * | 1997-05-15 | 2000-05-09 | Regents Of The University Of Minnesota | Method and apparatus for use with MR imaging |
| AU7702798A (en) * | 1997-05-30 | 1998-12-30 | Alliance Pharmaceutical Corporation | Methods and apparatus for monitoring and quantifying the movement of fluid |
| DE19731300C1 (de) | 1997-07-11 | 1999-01-21 | Schering Ag | Perfluoralkylgruppenhaltige Trijodaromaten, Verfahren zu deren Herstellung und deren Verwendung als Kontrastmittel |
| US6073042A (en) * | 1997-09-25 | 2000-06-06 | Siemens Medical Systems, Inc. | Display of three-dimensional MRA images in which arteries can be distinguished from veins |
| ATE254479T1 (de) | 1997-10-02 | 2003-12-15 | Epix Medical Inc | Verfahren für verbesserte kontrast- bilderzeugung zur therapieüberwachung |
| AU752812B2 (en) | 1997-11-17 | 2002-10-03 | Research Corporation Technologies, Inc. | Magnetic resonance imaging agents for the detection of physiological agents |
| GB2336680A (en) * | 1998-04-25 | 1999-10-27 | Marconi Gec Ltd | Imaging using a contrast agent |
| US6858210B1 (en) | 1998-06-09 | 2005-02-22 | La Jolla Pharmaceutical Co. | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same |
| JP2002522514A (ja) | 1998-08-10 | 2002-07-23 | ブラッコ・リサーチ・ソシエテ・アノニム | ポジティブｍｒｉコントラスト剤とネガティブｍｒｉコントラスト剤との組合せ |
| US6112112A (en) * | 1998-09-18 | 2000-08-29 | Arch Development Corporation | Method and system for the assessment of tumor extent in magnetic resonance images |
| US6342598B1 (en) | 1998-11-26 | 2002-01-29 | Bracco International B.V. | Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| US6399578B1 (en) | 1998-12-09 | 2002-06-04 | La Jolla Pharmaceutical Company | Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
| US6458953B1 (en) | 1998-12-09 | 2002-10-01 | La Jolla Pharmaceutical Company | Valency platform molecules comprising carbamate linkages |
| EP1203026A4 (fr) * | 1999-07-29 | 2005-03-16 | Dyax Corp | Fractions se liant la fibrine |
| NZ517017A (en) | 1999-07-29 | 2004-05-28 | Epix Medical Inc | Targeting multimeric imaging agents through multiocus binding and improving the efficacy of in vivo contrast agents |
| WO2002054088A2 (fr) * | 2001-01-05 | 2002-07-11 | Duke University | Agent ameliorateur de contraste en imagerie par resonance magnetique |
| US6549798B2 (en) | 2001-02-07 | 2003-04-15 | Epix Medical, Inc. | Magnetic resonance angiography data |
| US6459264B1 (en) * | 2001-02-22 | 2002-10-01 | Mayo Foundation For Medical Education And Research | Real-time embedded magnetic resonance fluoroscopy |
| EP1542709A2 (fr) * | 2002-08-06 | 2005-06-22 | EPIX Pharmaceuticals, Inc. | Agregats de peptides |
-
2002
- 2002-07-29 TW TW091116939A patent/TWI221406B/zh not_active IP Right Cessation
- 2002-07-30 PL PL02366736A patent/PL366736A1/xx not_active Application Discontinuation
- 2002-07-30 KR KR10-2004-7001273A patent/KR20040018529A/ko not_active Application Discontinuation
- 2002-07-30 MX MXPA04000955A patent/MXPA04000955A/es not_active Application Discontinuation
- 2002-07-30 US US10/209,416 patent/US7412279B2/en not_active Expired - Fee Related
- 2002-07-30 CN CNA028192532A patent/CN1635855A/zh active Pending
- 2002-07-30 WO PCT/US2002/024153 patent/WO2003011113A2/fr active Application Filing
- 2002-07-30 HU HU0401548A patent/HUP0401548A3/hu unknown
- 2002-07-30 IL IL15993702A patent/IL159937A0/xx unknown
- 2002-07-30 BR BR0211607-3A patent/BR0211607A/pt not_active Application Discontinuation
- 2002-07-30 JP JP2003516353A patent/JP2004536649A/ja active Pending
- 2002-07-30 CA CA002455210A patent/CA2455210A1/fr not_active Abandoned
- 2002-07-30 EP EP02756807A patent/EP1420689A4/fr not_active Withdrawn
- 2002-07-30 AU AU2002322789A patent/AU2002322789C1/en not_active Ceased
-
2004
- 2004-02-26 ZA ZA200401605A patent/ZA200401605B/en unknown
-
2005
- 2005-07-27 JP JP2005218095A patent/JP2006006962A/ja not_active Withdrawn
-
2008
- 2008-03-24 JP JP2008076834A patent/JP2008220966A/ja active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100581456C (zh) * | 2006-11-22 | 2010-01-20 | 株式会社东芝 | 磁共振成像装置 |
| US10098563B2 (en) | 2006-11-22 | 2018-10-16 | Toshiba Medical Systems Corporation | Magnetic resonance imaging apparatus |
| US10219721B2 (en) | 2006-11-22 | 2019-03-05 | Toshiba Medical Systems Corporation | Magnetic resonance imaging apparatus reconstructing rephase and dephase images |
| CN102188722A (zh) * | 2010-03-18 | 2011-09-21 | 中国科学院福建物质结构研究所 | 一种含二价铁的磁共振成像造影剂 |
| CN103519809A (zh) * | 2013-10-22 | 2014-01-22 | 深圳先进技术研究院 | 氧代谢参数估测方法和系统 |
| CN103519809B (zh) * | 2013-10-22 | 2015-11-04 | 深圳先进技术研究院 | 氧代谢参数估测方法和系统 |
| CN108430520A (zh) * | 2015-11-06 | 2018-08-21 | 威斯康星校友研究基金会 | 长效钆基肿瘤靶向成像与治疗剂 |
| CN106986920A (zh) * | 2017-03-09 | 2017-07-28 | 北京市心肺血管疾病研究所 | 四型胶原作为靶点在早期诊断主动脉瘤/夹层中的应用 |
| CN111738977A (zh) * | 2019-03-19 | 2020-10-02 | 西门子医疗有限公司 | 用于提供决策支持数据的方法和数据处理系统 |
| CN112426143A (zh) * | 2020-11-16 | 2021-03-02 | 清华大学 | 一种肾动脉及腹主动脉一站式无创磁共振血管壁成像系统 |
| CN112426143B (zh) * | 2020-11-16 | 2021-07-23 | 清华大学 | 一种肾动脉及腹主动脉一站式无创磁共振血管壁成像系统 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1420689A2 (fr) | 2004-05-26 |
| CA2455210A1 (fr) | 2003-02-13 |
| PL366736A1 (en) | 2005-02-07 |
| JP2006006962A (ja) | 2006-01-12 |
| HUP0401548A2 (hu) | 2005-08-29 |
| TWI221406B (en) | 2004-10-01 |
| US7412279B2 (en) | 2008-08-12 |
| EP1420689A4 (fr) | 2009-01-28 |
| WO2003011113A2 (fr) | 2003-02-13 |
| JP2008220966A (ja) | 2008-09-25 |
| ZA200401605B (en) | 2005-04-05 |
| MXPA04000955A (es) | 2005-02-17 |
| HUP0401548A3 (en) | 2010-01-28 |
| IL159937A0 (en) | 2004-06-20 |
| JP2004536649A (ja) | 2004-12-09 |
| WO2003011113A3 (fr) | 2003-07-03 |
| KR20040018529A (ko) | 2004-03-03 |
| US20030028101A1 (en) | 2003-02-06 |
| AU2002322789B2 (en) | 2006-04-13 |
| BR0211607A (pt) | 2004-08-24 |
| AU2002322789C1 (en) | 2006-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1635855A (zh) | 靶向血管系统的磁共振成像系统和方法 | |
| CN101077301A (zh) | 图像处理装置和磁共振成像装置 | |
| CN1177806C (zh) | 可延长血液潴留的诊断成像用造影剂 | |
| Beyer et al. | What scans we will read: imaging instrumentation trends in clinical oncology | |
| Teifke et al. | Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis | |
| CN1718164A (zh) | 超声波诊断装置、图像处理装置和图像处理方法 | |
| Langer et al. | Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2—sparse versus dense cancers | |
| CN1600268A (zh) | 血流分析装置以及血流分析方法 | |
| Heusch et al. | Diagnostic accuracy of ultrasound, 18 F-FDG-PET/CT, and fused 18 F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC | |
| CN101039627A (zh) | 超声波诊断装置及超声波诊断装置的控制方法 | |
| Arita et al. | Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma | |
| CN1905836A (zh) | 磁共振成像装置、图像数据修正装置和图像数据修正方法 | |
| CN1636520A (zh) | 超声波诊断装置 | |
| CN1599577A (zh) | 肽基多聚体靶向的造影介质 | |
| CN1558738A (zh) | 超声波诊断设备、工作流程编辑系统和控制超声波诊断设备的方法 | |
| CN1639725A (zh) | 图像像素编码方法、图像处理方法和针对一个或多个图像像素再现的对象进行定性识别的图像处理方法 | |
| CN1432341A (zh) | 使用定位待成像多板块技术的磁共振成像 | |
| Johansen et al. | Quantitative molecular imaging with a single Gd-based contrast agent reveals specific tumor binding and retention in vivo | |
| CN1795015A (zh) | 螯合配位体和造影剂的光学纯和光学富集异构体 | |
| Zeng et al. | Assessment of early hepatic echinococcus multilocularis infection in rats with real-time contrast-enhanced ultrasonography | |
| Maier et al. | Multiparametric immunoimaging maps inflammatory signatures in murine myocardial infarction models | |
| CN1781447A (zh) | 使用定位待成像多板块技术的磁共振成像 | |
| You et al. | Relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerostic plaque in rabbit model | |
| Wamasing et al. | Differentiation of cystic lesions in the jaw by conventional magnetic resonance imaging and diffusion-weighted imaging | |
| CN101039702A (zh) | 作为靶向试剂用于内皮－特异性体内转导的热激蛋白 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |